Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDeferred TaxesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet Income
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNYNF) Non-cash Items (2016 - 2021)

Historic Non-cash Items for Sanofi (SNYNF) over the last 13 years, with Q2 2021 value amounting to $5.1 billion.

  • Sanofi's Non-cash Items rose 715.85% to $5.1 billion in Q2 2021 from the same period last year, while for Jun 2021 it was $9.8 billion, marking a year-over-year increase of 144.11%. This contributed to the annual value of $9.9 billion for FY2025, which is 74.99% down from last year.
  • Latest data reveals that Sanofi reported Non-cash Items of $5.1 billion as of Q2 2021, which was up 715.85% from -$53.1 million recorded in Q1 2021.
  • Over the past 5 years, Sanofi's Non-cash Items peaked at $10.5 billion during Q4 2017, and registered a low of -$220.3 million during Q4 2018.
  • Moreover, its 5-year median value for Non-cash Items was $2.5 billion (2019), whereas its average is $3.1 billion.
  • In the last 5 years, Sanofi's Non-cash Items soared by 224552.27% in 2017 and then crashed by 230386.39% in 2021.
  • Over the past 5 years, Sanofi's Non-cash Items (Quarter) stood at $10.5 billion in 2017, then crashed by 102.1% to -$220.3 million in 2018, then soared by 2249.96% to $4.7 billion in 2019, then rose by 0.51% to $4.8 billion in 2020, then grew by 7.16% to $5.1 billion in 2021.
  • Its last three reported values are $5.1 billion in Q2 2021, -$53.1 million for Q1 2021, and $4.8 billion during Q2 2020.